Cargando…

Varying faecal immunochemical test positivity thresholds impacts colorectal cancer detection

BACKGROUND: Colorectal cancer (CRC) is screened for by the faecal immunochemical test (FIT) in Ireland. The FIT positivity threshold in Ireland is 45 micrograms (µg) of haemoglobin per gram (g) of stool. FIT positivity thresholds influence both demand for screening colonoscopies and CRC detection ra...

Descripción completa

Detalles Bibliográficos
Autores principales: White, P, Muraleedharan, R, Mooney, T, Smith, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597021/
http://dx.doi.org/10.1093/eurpub/ckad160.1392
_version_ 1785125243479654400
author White, P
Muraleedharan, R
Mooney, T
Smith, A
author_facet White, P
Muraleedharan, R
Mooney, T
Smith, A
author_sort White, P
collection PubMed
description BACKGROUND: Colorectal cancer (CRC) is screened for by the faecal immunochemical test (FIT) in Ireland. The FIT positivity threshold in Ireland is 45 micrograms (µg) of haemoglobin per gram (g) of stool. FIT positivity thresholds influence both demand for screening colonoscopies and CRC detection rates through screening. This study aimed to assess the impact of varying FIT positivity thresholds on CRC detection rates through screening in Ireland. METHODS: This study used data from BowelScreen - The National Bowel Screening Programme, to retrospectively assess the impact of altering the FIT positivity threshold, adjusting it to correspond with neighbouring European countries, on CRC detection rates through screening in Ireland between 2013 and 2021. All analyses were conducted on Stata 17. RESULTS: 1,552 individuals were diagnosed with CRC in Ireland after a positive FIT performed through BowelScreen between 2013-2021. Adopting the same FIT positivity thresholds as the Netherlands (47µg/g), Scotland (80µg/g), England (120µg/g) and Wales (150µg/g) would have resulted in 21 (1.4%), 262 (17.1%), 458 (29.8%) and 556 (36.2%) fewer diagnoses of CRC through BowelScreen during this period, respectively. Additionally, increasing the positivity threshold to correspond with these countries would have resulted in between 1.7-41.9% fewer stage 1, between 1.0-30.9% fewer stage 2, between 1.4-32.9% fewer stage 3 and between 0-5.6% fewer stage 4 CRCs detected. CONCLUSIONS: Changing the FIT positivity threshold in Ireland to correspond with that of other neighbouring European countries would have reduced the detection of CRC through screening to varying degrees. The detection of stage 1 CRCs would have been most greatly reduced, but up to almost a third of all stage 2 and stage 3 CRCs would not have been detected if some alternative, higher positivity thresholds were adopted. KEY MESSAGES: • Increasing the FIT positivity threshold in Ireland will need careful consideration to keep the optimum positive predictive value of a colonoscopy. • Lower stage 1-3 CRC detection rates may occur as a result.
format Online
Article
Text
id pubmed-10597021
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105970212023-10-25 Varying faecal immunochemical test positivity thresholds impacts colorectal cancer detection White, P Muraleedharan, R Mooney, T Smith, A Eur J Public Health Poster Displays BACKGROUND: Colorectal cancer (CRC) is screened for by the faecal immunochemical test (FIT) in Ireland. The FIT positivity threshold in Ireland is 45 micrograms (µg) of haemoglobin per gram (g) of stool. FIT positivity thresholds influence both demand for screening colonoscopies and CRC detection rates through screening. This study aimed to assess the impact of varying FIT positivity thresholds on CRC detection rates through screening in Ireland. METHODS: This study used data from BowelScreen - The National Bowel Screening Programme, to retrospectively assess the impact of altering the FIT positivity threshold, adjusting it to correspond with neighbouring European countries, on CRC detection rates through screening in Ireland between 2013 and 2021. All analyses were conducted on Stata 17. RESULTS: 1,552 individuals were diagnosed with CRC in Ireland after a positive FIT performed through BowelScreen between 2013-2021. Adopting the same FIT positivity thresholds as the Netherlands (47µg/g), Scotland (80µg/g), England (120µg/g) and Wales (150µg/g) would have resulted in 21 (1.4%), 262 (17.1%), 458 (29.8%) and 556 (36.2%) fewer diagnoses of CRC through BowelScreen during this period, respectively. Additionally, increasing the positivity threshold to correspond with these countries would have resulted in between 1.7-41.9% fewer stage 1, between 1.0-30.9% fewer stage 2, between 1.4-32.9% fewer stage 3 and between 0-5.6% fewer stage 4 CRCs detected. CONCLUSIONS: Changing the FIT positivity threshold in Ireland to correspond with that of other neighbouring European countries would have reduced the detection of CRC through screening to varying degrees. The detection of stage 1 CRCs would have been most greatly reduced, but up to almost a third of all stage 2 and stage 3 CRCs would not have been detected if some alternative, higher positivity thresholds were adopted. KEY MESSAGES: • Increasing the FIT positivity threshold in Ireland will need careful consideration to keep the optimum positive predictive value of a colonoscopy. • Lower stage 1-3 CRC detection rates may occur as a result. Oxford University Press 2023-10-24 /pmc/articles/PMC10597021/ http://dx.doi.org/10.1093/eurpub/ckad160.1392 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Displays
White, P
Muraleedharan, R
Mooney, T
Smith, A
Varying faecal immunochemical test positivity thresholds impacts colorectal cancer detection
title Varying faecal immunochemical test positivity thresholds impacts colorectal cancer detection
title_full Varying faecal immunochemical test positivity thresholds impacts colorectal cancer detection
title_fullStr Varying faecal immunochemical test positivity thresholds impacts colorectal cancer detection
title_full_unstemmed Varying faecal immunochemical test positivity thresholds impacts colorectal cancer detection
title_short Varying faecal immunochemical test positivity thresholds impacts colorectal cancer detection
title_sort varying faecal immunochemical test positivity thresholds impacts colorectal cancer detection
topic Poster Displays
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597021/
http://dx.doi.org/10.1093/eurpub/ckad160.1392
work_keys_str_mv AT whitep varyingfaecalimmunochemicaltestpositivitythresholdsimpactscolorectalcancerdetection
AT muraleedharanr varyingfaecalimmunochemicaltestpositivitythresholdsimpactscolorectalcancerdetection
AT mooneyt varyingfaecalimmunochemicaltestpositivitythresholdsimpactscolorectalcancerdetection
AT smitha varyingfaecalimmunochemicaltestpositivitythresholdsimpactscolorectalcancerdetection